Progression in Near-Infrared Fluorescence Imaging Technology for Lung Cancer Management
Biosensors,
Journal Year:
2024,
Volume and Issue:
14(10), P. 501 - 501
Published: Oct. 14, 2024
Lung
cancer
is
a
major
threat
to
human
health
and
leading
cause
of
death.
Accurate
localization
tumors
in
vivo
crucial
for
subsequent
treatment.
In
recent
years,
fluorescent
imaging
technology
has
become
focal
point
tumor
diagnosis
treatment
due
its
high
sensitivity,
strong
selectivity,
non-invasiveness,
multifunctionality.
Molecular
probes-based
not
only
enables
real-time
through
fluorescence
signals
but
also
integrates
therapeutic
functions,
drug
screening,
efficacy
monitoring
facilitate
comprehensive
Among
them,
near-infrared
(NIR)
particularly
prominent
improved
effect.
This
trend
toward
multifunctionality
significant
aspect
the
future
advancement
technology.
past
great
progress
been
made
field
NIR
lung
management,
as
well
emergence
new
problems
challenges.
paper
generally
summarizes
application
these
areas
five
including
design,
detection
principles,
clinical
applications,
with
aim
advancing
more
efficient
technologies
enhance
accuracy
Language: Английский
Near-Infrared Photoimmunotherapy for Thoracic Cancers: A Translational Perspective
Kohei Matsuoka,
No information about this author
Mizuki Yamada,
No information about this author
Mitsuo Sato
No information about this author
et al.
Biomedicines,
Journal Year:
2022,
Volume and Issue:
10(7), P. 1662 - 1662
Published: July 11, 2022
The
conventional
treatment
of
thoracic
tumors
includes
surgery,
anticancer
drugs,
radiation,
and
cancer
immunotherapy.
Light
therapy
for
has
long
been
used
as
an
alternative;
light
also
called
photodynamic
(PDT)
mainly
early-stage
lung
cancer.
Recently,
near-infrared
photoimmunotherapy
(NIR-PIT),
which
is
a
completely
different
concept
from
PDT,
developed
approved
in
Japan
the
recurrent
previously
treated
head
neck
because
its
specificity
effectiveness.
NIR-PIT
can
apply
to
any
target
by
changing
antigens.
In
recent
years,
it
become
clear
that
various
specific
promising
targets
are
highly
expressed
tumors.
combination
with
these
targets,
expected
be
ideal
therapeutic
approach
Additionally,
techniques
being
further
develop
clinical
practice.
this
review,
introduced,
potential
applications
cancers
described.
Language: Английский
Contrast-enhanced ultrasound imaging for monitoring the efficacy of near-infrared photoimmunotherapy
Kohei Matsuoka,
No information about this author
Mizuki Yamada,
No information about this author
Noriaki Fukatsu
No information about this author
et al.
EBioMedicine,
Journal Year:
2023,
Volume and Issue:
95, P. 104737 - 104737
Published: Aug. 7, 2023
Near-infrared
photoimmunotherapy
(NIR-PIT)
is
a
promising
cancer
therapy
combining
NIR-light
irradiation
with
an
antibody
and
IR700DX,
light-sensitive
substance,
to
destroy
tumours.
However,
homogeneous
difficult
because
the
light
varies
depending
on
distance
tissue
environment.
Therefore,
markers
that
indicate
sufficient
are
necessary.
Nanoparticles
sized
10∼200
nm
show
enhanced
permeation
retention
within
tumours,
which
further
via
NIR-PIT
(super
permeability
retention,
SUPR).
We
aimed
monitor
effectiveness
of
by
measuring
SUPR.A
xenograft
mouse
tumour
model
was
established
inoculating
human
cells
in
both
buttocks
Balb/C-nu/nu
mice,
performed
only
one
side.
To
evaluate
SUPR,
fluorescent
signal
examination
using
QD800-fluorescent
nanoparticles
NIR-fluorescent
poly
(d,l-lactide-co-glycolic
acid)
(NIR-PLGA)
microparticles.
Harmonic
signals
were
evaluated
micro-bubbles
contrast
agent
Sonazoid
contrast-enhanced
ultrasound
(CEUS)
imaging.
The
correlation
between
SUPR
immediately
after
treatment
day
evaluated.QD800
persisted
treated
intensity
remaining
showed
high
positive
therapeutic
effect.
NIR-PLGA
Sonazoid-derived
harmonic
remained
for
longer
time
tumours
than
controls,
kE
value
two-compartment
correlated
effectiveness.SUPR
measurement
CEUS
imaging
could
be
easily
adapted
clinical
use
as
image-based
biomarker
monitoring
confirming
efficacy.This
research
supported
ARIM
JAPAN
MEXT,
Program
Developing
Next-generation
Researchers
(Japan
Science
Technology
Agency),
KAKEN
(18K15923,
21K07217)
(JSPS),
CREST
(JPMJCR19H2,
JST),
FOREST-Souhatsu
(JST).
Mochida
Memorial
Foundation
Medical
Pharmaceutical
Research;
Takeda
Foundation;
Japan
Health
Princess
Takamatsu
Cancer
Research
Fund.
Funders
provided
financial
support
had
no
role
study
design,
data
collection,
analysis,
interpretation,
writing
report.
Language: Английский
Recent Advances in Localized Immunomodulation Technology: Application of NIR-PIT toward Clinical Control of the Local Immune System
Mizuki Yamada,
No information about this author
Kohei Matsuoka,
No information about this author
Mitsuo Sato
No information about this author
et al.
Pharmaceutics,
Journal Year:
2023,
Volume and Issue:
15(2), P. 561 - 561
Published: Feb. 7, 2023
Current
immunotherapies
aim
to
modulate
the
balance
among
different
immune
cell
populations,
thereby
controlling
reactions.
However,
they
often
cause
overactivation
or
over-suppression,
which
makes
them
difficult
control.
Thus,
it
would
be
ideal
manipulate
cells
at
a
local
site
without
disturbing
homeostasis
elsewhere
in
body.
Recent
technological
developments
have
enabled
selective
targeting
of
and
tissues
Photo-targeted
specific
therapy
has
recently
emerged
these.
Near-infrared
photoimmunotherapy
(NIR-PIT)
surfaced
as
new
modality
for
cancer
treatment,
combines
antibodies
photoabsorber,
IR700DX.
NIR-PIT
is
testing
an
international
phase
III
clinical
trial
locoregional
recurrent
head
neck
squamous
carcinoma
(HNSCC)
patients
(LUZERA-301,
NCT03769506),
with
fast-track
designation
by
United
States
Food
Drug
Administration
(US-FDA).
In
Japan,
was
conditionally
approved
2020.
Although
commonly
used
therapy,
could
also
exploited
locally
eliminate
certain
marker.
This
strategy
can
utilized
anti-allergic
therapy.
Herein,
we
discuss
recent
advances
immunomodulation
technology.
We
introduce
technology
demonstrate
example
knockdown
regulatory
T
(Tregs)
enhance
anti-tumor
Language: Английский
Evaluation of a Novel Lateral Emitting Laser Fiber for Near-Infrared Photoimmunotherapy
Cancers,
Journal Year:
2024,
Volume and Issue:
16(14), P. 2558 - 2558
Published: July 17, 2024
Near-infrared
photoimmunotherapy
(NIR-PIT)
is
a
new
cancer
therapy
that
uses
NIR
light
and
conjugates
of
tumor-targeting
monoclonal
antibody
phthalocyanine
dye.
In
clinical
practice,
frontal
cylindrical
diffusers
are
the
only
options
for
illumination.
However,
illumination
in
narrow
space
technically
difficult
with
such
diffusers.
Therefore,
we
evaluated
lateral
system
using
emitting
laser
(LEL)
fiber.
The
LEL
fiber
illuminated
certain
area
direction.
NIR-PIT
an
reduced
luciferase
activity
light-dose-dependent
manner
A431-GFP-luc
cells
vitro
significantly
suppressed
tumor
proliferation
xenograft
mouse
model.
To
evaluate
usefulness
space,
was
from
inside
cylinder,
mimicking
fluorescence
intensity
monitored.
diffuser,
unevenly
delivered
little
reached
distal
side.
By
contrast,
allowed
uniform
entire
tumor,
loss
observed
even
areas.
These
findings
suggested
can
be
used
suitable
space.
Language: Английский